Leta i den här bloggen


Visar inlägg med etikett gastrinen musiini. Visa alla inlägg
Visar inlägg med etikett gastrinen musiini. Visa alla inlägg

lördag 10 november 2018

(2000) Alkoholin vaikutus musiineihin . Musiinia sitova proteiini MBP.

https://www.ncbi.nlm.nih.gov/pubmed/11016863
J 2000 Sep;51(3):433-47.

Impact of ethanol on innate protection of gastric mucosal epithelial surfaces and the risk of injury. Slomiany A1, Piotrowski E, Piotrowski J, Slomiany BL. Abstract

 (Suomennosta astaktista)
Aiemmat tutkimukset etanolin vaikutuksesta  gastrisen mucus -glykoproteiinin ( musiinin)  synteesiin ja posttranslationaaliseen glykosylaatioon paljastavat  kvantitatiivisia  muutoksia apoproteiinin koostumuksessa, glykosylaatiossa ja musiinin sitoutumisessa   mukosapintaan  (Alkoholismista 1998).

Tehtiin tutkimus koe-eläimillä  ja mitattiin   8- viikkoisen  etanolidieetin nauttimisen metabolisia seuraamuksia selvittäen,  olisiko in vivo tulokset  samanlaisia kuin in vitro -järjestelmästä saadut. Musiinin pidättymistä  limakalvopintaan  mitattiin kvantitatiivisesti  gastrista mukusta sitovan proteiinin (MBP) kiinnittymisestä  mahalaukun limakalvoon. Tuloksia verrattiin verrokkiin, jolla oli isokalorinen kontrollidieetti. Ennen alkoholin antoa ja kahden viikon välein etanolidieetin antamisesta kerättiin mahasisällöt ja musiini puhdistettiin.   Kahdeksan viikon kuluttua eläimet lopetettiin ja mahalaukkujen limakalvot otettiin MBP-preparaateiksi. Mitattiin  kvantitatiivisesti MBP:n entsyymiin linkityn lektiinin avulla sitoutuminen musiiniin ennen etanolia ja  2, 4, 6, ja 8 viikon  kuluttua  etanolidieetin alkamisesta.
  Standardimusiinitutkimuksesta selvisi, että  yksilöiden välillä on  kohtalaisesti individuaalisia eroja  musiinin sitoutumisessa MBP-proteiiniin.  Sama vaihtelevuus havaittiin  myös  näytteissä, jotka oli kerätty ennen koedieetin alkamista. Kuitenkin etanolidieetin  pitkittyessä  aluksi ilmenneen variabiliteetin ja yksilöistä johtuvien erojen lisäksi situtumisessa tapahtui  myös dramaattinen väheneminen. Viidessä koe-eläimessä  musiinin sitoutuminen MBP-proteiiniin väheni kahden viikon etanolidieetistä  50% ja yhdellä koe-eläimella  vähenemä oli 20% kuuden viikon ajana ja  viimeisessä näyteessä sitoutuminen oli vähentynyt 50%:iin.   Kahdella  koe-eläimellä kokeen lopussa oli  sitoutumiskapasiteetista jäljellä vain 6-9 % alkukapasiteetista.

Tulokset  yksittäisten eläinten musiinitutkimuksista ja MBP-preparaattien   verrokkikontrolli-valmisteista  osoittavat, että   joka eläin ilmentää  eri asteista musiinien sitoutumista. Lisäksi kroonisessa  etanolin käytössä yksilöeroihin  tulee lisänä  lasku musiinin sitoutumisessa MBP- proteiiniin. Koska havaittu siotutumisen alenema näyteissä ilmeni  näyteissä, jotka  sisälsivät  samaa MBP-preparaattia,  alkoholin vaikuttama komponentti  sijaitsi musiinilla.
Johtopäätöksenään tutkijat ovat sitä mieltä, että etanoli vaikuttaa MBP-proteiinin sitoutumiseen tarvittavaan   musiini-olikosakkaridistruktuurin synteesiin ja pysymiseen gastrisen  limakalvopinnalla He perustavat  johtopäätöksensä in vitro  tutkimuksista saatuun havaintoon etanolin vaikutuksesta  hiilihydraattiketjun kehkeytymiseen Golgin laitteessa  ja  löytöönsä   musiini-oligosakkarideista riippuvaan musiini-MBP-kompleksin muodostumiseen.
  • Earlier investigations on the effect of ethanol on synthesis and posttranlational glycosylation of gastric mucus glycoprotein (mucin) revealed quantitative changes in the apoprotein assembly, glycosylation, and mucin retention on the mucosal surface (Slomiany et al.., Alcoholism: Clin. Exp. Res. 21, 417-423, 1998).
  •  To assess whether metabolic consequences of ethanol ingestion, documented in the in vitro system are also occurring in vivo the rats were subjected to 8 weeks of ethanol containing liquid diet. The retention of mucin on the surface of gastric mucosa was quantitated by measuring the binding of gastric mucin to Mucin Binding Protein (MBP) of gastric mucosa. The results were compared with those obtained with the rats subjected to pair-feeding the isocaloric-control diet. Before alcohol administration, and in two weeks' intervals thereafter, the gastric contents from the animals was collected and mucin purified. After 8 weeks of the respective diet, the animals were sacrificed and their gastric mucosa used for MBP preparation. The binding of mucin to MBP before ethanol, and after 2, 4, 6, and 8 weeks of ethanol diet was quantitated with Enzyme Linked Lectin Assay (ELLA). 
  • The study with standard mucin revealed that binding of mucin to MBP differs substantially between individual animals. The same variability in binding was observed with the individual mucin preparations collected at the onset of the experiment. However, with the progression of ethanol feeding, the mucin samples besides displaying the variable and animal-specific binding to MBP at the initiation of the experiment, also showed a dramatic decrease in binding. In five animals, after two weeks of ethanol diet, mucin binding to MBP decreased by 50%; in two animals, the drastic decrease in binding was observed in mucin collected after four weeks of alcohol feeding; and in one animal a 20% decrease in binding persisted for six weeks, and then decreased to 50% in the last collection. Also, in two animals, the mucin collected after 8 weeks of ethanol feeding retained only 6-9% of the initial binding capacity. In contrast, in pair-fed controls, the mucin binding to MBP remained the same or increased up to 20%.
  •  Results of the studies, performed on mucin of the individual animals and matching preparations of MBP, showed that each animal expresses different degree of mucin binding. Moreover, in chronic ethanol ingestion, the individual variations are accompanied by a decrease in mucin binding to MBP. Since the observed decrease in binding occurred in samples containing the same preparation of MBP, the component affected by alcohol resides on mucin. Thus, considering the in vitro impact of ethanol on generation of carbohydrate chains in Golgi, and the finding on mucin oligosaccharides-dependent mucin-MBP complex formation, we conclude that ethanol impairs the synthesis of mucin oligosaccharide structures required for binding with MBP, and the retention on gastric mucosal surfaces.
Free full text
(Suomennos muistiin 10.11. 2018)
Mikä on MBP, gastrista musiinia sitova proteiini? 
Tästä tarkemmin:
 Thus, understanding how both acute and chronic alcohol exposure disrupt the homeostatic gastrointestinal tract is paramount. This article will review relevant studies examining the role of gut epithelia in defense against pathogenic bacteria within the gut and the impact of alcohol on intestinal immunity, highlighting T cells and neutrophils. Finally, it will review how the gut microbiome plays a role in maintenance of gut barrier integrity following alcohol exposure and trauma.

Intestinal Anatomy and Histology
To fully understand the intricate relationships among the gut barrier, immune system, and microbiome, gastrointestinal (GI) anatomy requires review. The spatial relationships established between the lumen and barrier of the gut are essential for the proper function of the GI tract in digestion and nutrient absorption. The GI tract is a continuous tube that begins at the mouth and ends at the anus. The small and large intestines function mainly to absorb nutrients and water, and this review will focus on these organs.
The small intestine is divided into three regions: the duodenum, jejunum, and ileum, respectively. At the distal end of the ileum lies the cecum, which connects the small and large intestines. From the cecum, the large intestine (colon) is composed of four regions: the ascending, transverse, descending and sigmoid colon, respectively, terminating in the rectum and anus. The small and large intestines are held in place to prevent twisting by the mesentery, which also contains the mesenteric lymph nodes (MLNs). As shown in figure 1, the small and large intestines at the histological level contain a barrier of mucous and epithelial cells that block the translocation of bacteria in the lumen to sites in the body beyond the intestines. Just below the intestinal epithelia lies a layer of loose connective tissue called the lamina propria (LP), which connects the surface mucosal epithelium to the basement muscularis mucosae. The LP also contains a large number of intestinal immune cells. In addition, specialized regions within the small intestine called Peyer’s patches (PPs) serve as lymphoid follicles, where naïve immune cells differentiate into a variety of mature immune cell subsets.

Overview of the intestinal barrier, immune cells, and microbiome. Lumenal bacteria (red and green) are relegated to the lumen of the intestine  

tisdag 6 november 2018

MUC6 (11p15.5), MUC-6 koodaa sekretorista musiinia 6. Ainutlaatuinen rakenne.

MUC6 (11p15.5)

(Suomennosta) Tämä geeni tunnetaan kahdella nimellä: MUC6 tai MUC-6. Geeni koodaa musiinia, joka erittyy ja muoodstaa läpäisemätöntä puolustusestettä, joka suojaa suolen ontelon pintaa. Geeniä ilmenee mahalaukussa ja pohjukaissuolessa. Proteiinin nimen on musiini-6.
  • Also known as MUC-6
  • Summary This gene encodes a member of the mucin protein family. Mucins are high molecular weight glycoproteins produced by many epithelial tissues. The protein encoded by this gene is secreted and forms an insoluble mucous barrier that protects the gut lumen. [provided by RefSeq, Dec 2016] Expression Biased expression in stomach (RPKM 174.6) and duodenum (RPKM 41.3) See more Orthologs mouse all Preferred Names mucin-6. Names gastric mucin-6
Artikkeleita

Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer. Ohya A, et al. Cancer Sci, 2017 Sep. PMID 28685935, Free PMC Article
  1. MUC6 mucin expression inhibits tumor cell invasion. Leir SH, et al. Exp Cell Res, 2011 Oct 15. PMID 21851820
  2. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6. Gibson JA, et al. Am J Surg Pathol, 2011 May. PMID 21490447
  3. Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses. Freire T, et al. J Biol Chem, 2011 Mar 11. PMID 21193402, Free PMC Article
Gene rif
(Finnish)  otan tässä esiin  musiini-6 rakenteen prekursorimolekyylin 
 
    See identical proteins and their annotated locations for NP_005952.2
     
    (Finnish)  Konservoituja domeeneja ovat 
     
    BDLF3 (https://www.mybiosource.com/prods/Recombinant-Protein/Probable-membrane-antigen-GP85-BDLF3/BDLF3/datasheet.php?products_id=7062925)
  1. Conserved Domains (8) summary
    PHA03255
    Location:2188 → 2343
    PHA03255; BDLF3; Provisional
    smart00041
    Location:2351 → 2434
    CT; C-terminal cystine knot-like domain (CTCK)
    smart00215
    Location:359 → 403
    VWC_out; von Willebrand factor (vWF) type C domain
    smart00216
    Location:386 → 549
    VWD; von Willebrand factor (vWF) type D domain
    pfam00094
    Location:868 → 1017
    VWD; von Willebrand factor type D domain
    pfam01826
    Location:302 → 357
    TIL; Trypsin Inhibitor like cysteine rich domain
    pfam08742
    Location:1057 → 1127
    C8; C8 domain
    cl17735
    Location:829 → 886
    VWC; von Willebrand factor type C domain



(Finnish)  Historiallisia  vaiheita.
  • mucin-6 precursor [Homo sapiens]
  • NCBI Reference Sequence: NP_005952.2
  • LOCUS       NP_005952               2439 aa            linear   PRI 19-AUG-2018
    DEFINITION  mucin-6 precursor [Homo sapiens].
    
(Finnish)  2018  Referenssi 1. Helikobacter pylori- virulenssitekijän Cag A ja ammoniumjonin vaikutus musiineihin AGS-soluissa:  vaikutusta on myös MUC6 ilmenemään.
  • REFERENCE   1  (residues 1 to 2439)
  AUTHORS   Zhang X, Shi D, Liu YP, Chen WJ and Wu D.
  TITLE     Effects of the Helicobacter pylori Virulence Factor CagA and
            Ammonium Ion on Mucins in AGS Cells
  JOURNAL   Yonsei Med. J. 59 (5), 633-642 (2018)
   PUBMED   29869461
  REMARK    GeneRIF: The expression of MUC5AC, MUC2, and MUC6 mRNA in
            CagA-transfected AGS cells at an NH concentration of 15 mM was
            significantly higher than that at 0 mM, and decreased at higher
            concentrations. H. pylori may affect the expression of MUC5AC,
            MUC2, MUC5B, and MUC6 in AGS cells via CagA and/or NH, but not
            E-cadherin.


(Finnish)  2018 referenssi 2. immunohitokemialliset musiiniantigeenikirjot
sylkirauhasen mukoepidermaalisessa karsinoomassa.
Varhaisessa postoperatiivisessa vaiheessa MUC4- ja MUC6 – 
negatiiviset ilmenemät ovat huonon ennusteen merkkejä. 

  • REFERENCE   2  (residues 1 to 2439)
  AUTHORS   Honjo K, Hiraki T, Higashi M, Noguchi H, Nomoto M, Yoshimura T,
            Batra SK, Yonezawa S, Semba I, Nakamura N, Tanimoto A and Yamada S.
  TITLE     Immunohistochemical expression profiles of mucin antigens in
            salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative
            expression predicts a shortened survival in the early postoperative
            phase
  JOURNAL   Histol. Histopathol. 33 (2), 201-213 (2018)
   PUBMED   28649694
  REMARK    GeneRIF: The detection of MUC4 and/or MUC6 might be a powerful
            parameter in the clinical management of mucoepidermoid carcinoma in
            the early postsurgical phase

(Finnish)  2017 referenssi 3. 
Maharauhasen musiinispesifinen O-glykaani-ilmenemä alenee
tuumorin progredioituessa  prekursorileesioista haimasyöväksi.
MUC6:een korreloivan alfaGlcNAc ilmenemän aleneminen tapahtuu 
varhain ja merkitsee  haimasyövän progredioitumisen alkamista.

  • REFERENCE   3  (residues 1 to 2439)
  AUTHORS   Ohya A, Yamanoi K, Shimojo H, Fujii C and Nakayama J.
  TITLE     Gastric gland mucin-specific O-glycan expression decreases with
            tumor progression from precursor lesions to pancreatic cancer
  JOURNAL   Cancer Sci. 108 (9), 1897-1902 (2017)
   PUBMED   28685935
  REMARK    GeneRIF: decreased expression of alphaGlcNAc relative to MUC6
            occurs early and marks the initiation of tumor progression to
            pancreatic cancer. 
 
(Finnish)  2016 Referenssi 4. 
Musiinigeenien MUC1, MUC2, MUC5AX ja MUC6  ilmenemisprofiilit ja
 kliininen merkitys kolorektaalissa syövässä.  MUC5AC geenin  ja
 erityisesti MUC6 geenin poikkeava ilmentymä assosioitui 
suotuisiin tuloksiin kolorektaalisyövässä  intermediäärisissä 
vaiheissa II ja III. 

  • REFERENCE   4  (residues 1 to 2439)
  AUTHORS   Betge J, Schneider NI, Harbaum L, Pollheimer MJ, Lindtner RA,
            Kornprat P, Ebert MP and Langner C.
  TITLE     MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression
            profiles and clinical significance
  JOURNAL   Virchows Arch. 469 (3), 255-265 (2016)
   PUBMED   27298226
  REMARK    GeneRIF: outcome, while the gain of aberrant expression of MUC5AC
            and particularly of MUC6 was associated with favorable outcome in
            colorectal cancer, notably in intermediate stages II and III’

(Finnish) 2015 referenssi 5. Musiinien MUC1, MUC2, MUC5AC ja MUC6
 ilmenemisprofiili ovariaalisessa musinoosissa tuumorissa: 
Ilmenemän muutokset   benigneistä rajatilaan ja  maligneihin tuumoreihin. 
  • REFERENCE   5  (residues 1 to 2439)
  AUTHORS   Wang J and El-Bahrawy M.
  TITLE     Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in
            ovarian mucinous tumours: changes in expression from benign to
            malignant tumours
  JOURNAL   Histopathology 66 (4), 529-535 (2015)
   PUBMED   25298197
  REMARK    GeneRIF: In ovarian mucinous tumors, MUC6 expression changes with
            the progression of benign to borderline and malignant tumours


(Finnish)  2004 referenssi 6. Ihmisen MUC6 ja MUC2 geenien täydellinen
genominen järjestäytyminen. Täydellinen  exoni/introni-organisoituminen. 

  • REFERENCE   6  (residues 1 to 2439)
  AUTHORS   Rousseau K, Byrne C, Kim YS, Gum JR, Swallow DM and Toribara NW.
  TITLE     The complete genomic organization of the human MUC6 and MUC2 mucin
            genes.
JOURNAL   Genomics 83 (5), 936-939 (2004)
   PUBMED   15081123
  REMARK    GeneRIF: complete genomic (exon/intron) organization 
 
 (Finnish) 1998 referenssi 7. MUC6 musiinigeeniä ilmenee 
 epiteelikudoksissa laajalla  variaatiolla.  

  • REFERENCE   7  (residues 1 to 2439)
  AUTHORS   Bartman AE, Buisine MP, Aubert JP, Niehans GA, Toribara NW, Kim YS,
            Kelly EJ, Crabtree JE and Ho SB.
  TITLE     MUC6 secretory mucin gene is expressed in a wide variety of
            epithelial tissues
  JOURNAL   J. Pathol. 186 (4), 398-405 (1998)
   PUBMED   10209489 
 
(Finnish) 1998 Referenss 8. Ihmisen musiinigeenit MUC2, MUC3, MUC4,
 MUS5AC ja MUC6  ilmentyvät vakaasti ja niillä on erittäin  laaja mRNA 
ja niissä ilmenee  vaihtelevaa pituuspolymorfiaa. On eräs parannettu
 tutkimusmetodi  laajojen mRNA- sekvenssien analysoimiseen. 
  • REFERENCE   8  (residues 1 to 2439)
  AUTHORS   Debailleul V, Laine A, Huet G, Mathon P, d'Hooghe MC, Aubert JP and
            Porchet N.
  TITLE     Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express
            stable and extremely large mRNAs and exhibit a variable length
            polymorphism. An improved method to analyze large mRNAs
  JOURNAL   J. Biol. Chem. 273 (2), 881-890 (1998)
   PUBMED   9422745

(Finnish)  1997 Referenssi 9. On analysoitu MUC6 -sekretorisen musiinin
 C-terminaali ja primaarinen aminohappojärjestys
  • REFERENCE   9  (residues 1 to 2439).
  AUTHORS   Toribara NW, Ho SB, Gum E, Gum JR Jr, Lau P and Kim YS.
  TITLE     The carboxyl-terminal sequence of the human secretory mucin, MUC6.
            Analysis Of the primary amino acid sequence
  JOURNAL   J. Biol. Chem. 272 (26), 16398-16403 (1997)
   PUBMED   9195947

(Finnish) 1993 referenssi 10.  Ihmisen gastrinen mukoosi. 
Ilmenemän kloonauksessa on tunnistettu  eräs  ainutlaatuinen laji. 
 
  •  
 REFERENCE   10 (residues 1 to 2439)
  AUTHORS   Toribara NW, Roberton AM, Ho SB, Kuo WL, Gum E, Hicks JW, Gum JR
            Jr, Byrd JC, Siddiki B and Kim YS.
  TITLE     Human gastric mucin. Identification of a unique species by
            expression cloning
  JOURNAL   J. Biol. Chem. 268 (8), 5879-5885 (1993)
   PUBMED   7680650

(Finnish)  Kommentti 2007 
Sekvenssin päivitys on tehty 25.7.2007. 
Aminohappoja  1..2439 ”mucin-6-prekursori”
1..22
23.. 2439 tuote ”Mucin-6”
Domeeneja:  
VWD,C8,TIL,VWC,VWD,C8,TIL,TIL,VWC,VWD,C8,Trunc,Appr.repeats,BDLF3,CT.  
  • COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC139749.4.
            This sequence is a reference standard in the RefSeqGene project.
            On or before Jul 25, 2007 this sequence version replaced
            XP_290540.7, XP_949181.2, NP_005952.1.
            
            Summary: This gene encodes a member of the mucin protein family.
            Mucins are high molecular weight glycoproteins produced by many
            epithelial tissues. The protein encoded by this gene is secreted
            and forms an insoluble mucous barrier that protects the gut lumen.
            [provided by RefSeq, Dec 2016].
            
            Sequence Note: The RefSeq transcript was derived from genomic
            sequence based on transcript alignments and the published
            description of the gene structure (PubMed ID 15081123).
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            RNAseq introns :: mixed/partial sample support SAMEA1968189,
                              SAMEA1968968 [ECO:0000350]
            ##Evidence-Data-END##
            
            ##RefSeq-Attributes-START##
            inferred exon combination :: based on alignments, homology
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..2439
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="11"
                     /map="11p15.5"
     Protein         1..2439
                     /product="mucin-6 precursor"
                     /note="mucin-6; gastric mucin-6"
                     /calculated_mol_wt=254750
     sig_peptide     1..22
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="{ECO:0000255}; propagated from UniProtKB/Swiss-Prot
                     (Q6W4X9.3)"
                     /calculated_mol_wt=2321
     mat_peptide     23..2439
                     /product="Mucin-6"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (Q6W4X9.3)"
                     /calculated_mol_wt=254750
     Region          40..192
                     /region_name="VWD"
                     /note="von Willebrand factor (vWF) type D domain;
                     smart00216"
                     /db_xref="CDD:214566"
     Region          228..297
                     /region_name="C8"
                     /note="C8 domain; pfam08742"
                     /db_xref="CDD:285899"
     Region          302..357
                     /region_name="TIL"
                     /note="Trypsin Inhibitor like cysteine rich domain;
                     pfam01826"
                     /db_xref="CDD:280072"
     Region          359..>403
                     /region_name="VWC_out"
                     /note="von Willebrand factor (vWF) type C domain;
                     smart00215"
                     /db_xref="CDD:214565"
     Region          386..549
                     /region_name="VWD"
                     /note="von Willebrand factor (vWF) type D domain;
                     smart00216"
                     /db_xref="CDD:214566"
     Region          588..660
                     /region_name="C8"
                     /note="C8 domain; pfam08742"
                     /db_xref="CDD:285899"
     Region          664..721
                     /region_name="TIL"
                     /note="Trypsin Inhibitor like cysteine rich domain;
                     pfam01826"
                     /db_xref="CDD:280072"
     Region          782..827
                     /region_name="TIL"
                     /note="Trypsin Inhibitor like cysteine rich domain;
                     pfam01826"
                     /db_xref="CDD:280072"
     Region          829..886
                     /region_name="VWC"
                     /note="von Willebrand factor type C domain; cl17735"
                     /db_xref="CDD:302663"
     Region          868..1017
                     /region_name="VWD"
                     /note="von Willebrand factor type D domain; pfam00094"
                     /db_xref="CDD:278521"
     Region          1057..1127
                     /region_name="C8"
                     /note="C8 domain; pfam08742"
                     /db_xref="CDD:285899"
     Region          1561..1738
                     /region_name="1, truncated"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (Q6W4X9.3)"
     Region          1607..1953
                     /region_name="Approximate repeats"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (Q6W4X9.3)"
     Region          2188..>2343
                     /region_name="PHA03255"
                     /note="BDLF3; Provisional"
                     /db_xref="CDD:165513"
     Region          2351..2434
                     /region_name="CT"
                     /note="C-terminal cystine knot-like domain (CTCK);
                     smart00041"
                     /db_xref="CDD:214482"
     CDS             1..2439
                     /gene="MUC6"
                     /gene_synonym="MUC-6"
                     /coded_by="NM_005961.2:52..7371"
                     /db_xref="CCDS:CCDS44513.1"
                     /db_xref="GeneID:4588"
                     /db_xref="HGNC:HGNC:7517"
                     /db_xref="MIM:158374"
ORIGIN      
        1 mvqrwlllsc cgallsagla ntsytspglq rlkdspqtap dkgqcstwga ghfstfdhhv
       61 ydfsgtcnyi faatckdafp tfsvqlrrgp dgsisriive lgasvvtvse aiisvkdigv
      121 islpytsngl qitpfgqsvr lvakqlelel evvwgpdshl mvlverkymg qmcglcgnfd
      181 gkvtnefvse egkflephkf aalqklddpg eictfqdips thvrqaqhar ictqlltlva
      241 pecsvskepf vlscqadvaa apqpgpqnss catlseysrq csmvgqpvrr wrspglcsvg
      301 qcpanqvyqe cgsacvktcs npqhscsssc tfgcfcpegt vlndlsnnht cvpvtqcpcv
      361 lhgamyapge vtiaacqtcr ctlgrwvcte rpcpghcsle ggsfvttfda rpyrfhgtct
      421 yillqspqlp edgalmavyd ksgvshsets lvavvylsrq dkivisqdev vtnngeakwl
      481 pyktrnitvf rqtsthlqma tsfglelvvq lrpifqayvt vgpqfrgqtr glcgnfngdt
      541 tddfttsmgi aegtaslfvd swragncpaa leretdpcsm sqlnkvcaet hcsmllrtgt
      601 vferchatvn papfykrcvy qacnyeetfp hicaalgdyv hacslrgvll wgwrssvdnc
      661 tipctgnttf synsqacert clslsdrate chhsavpvdg cncpdgtyln qkgecvrkaq
      721 cpcilegykf ilaeqstvin gitchcingr lscpqrpqmf lascqapktf kscsqssenk
      781 fgaacaptcq mlatgvacvp tkcepgcvca eglyenadgq cvppeecpce fsgvsypgga
      841 elhtdcrtcs csrgrwacqq gthcpstctl ygeghvitfd gqrfvfdgnc eyilatdvcg
      901 vndsqptfki ltenvicgns gvtcsraiki flgglsvvla drnytvtgee phvqlgvtpg
      961 alslvvdisi pgrynltliw nrhmtiliri arasqdplcg lcgnfngnmk ddfetrsryv
     1021 asselelvns wkesplcgdv sfvtdpcsln afrrswaerk csvinsqtfa tchskvyhlp
     1081 yyeacvrdac gcdsggdcec lcdavaayaq acldkgvcvd wrtpafcpiy cgfynthtqd
     1141 ghgeyqytqe anctwhyqpc lcpsqpqsvp gsniegcync sqdeyfdhee gvcvpcmppt
     1201 tpqppttpql pttgsrptqv wpmtgtstti gllsstgpsp ssnhtpaspt qtpllpatlt
     1261 sskptassge pprpttavtp qatsglppta tlrstatkpt vtqattrata staspattst
     1321 aqsttrttmt lptpatsgts ptlpkstnqe lpgttatqtt gprptpastt gpttpqpgqp
     1381 trptatettq trttteyttp qtphtthspp tagspvpstg pvtatsfhat ttyptpshpe
     1441 ttlpthvppf stslvtpsth tvitpthaqm atsasnhsap tgtipppttl katgsthtap
     1501 pitpttsgts qahssfstnk tptslhshts sthhpevtpt stttitpnpt strtrtpvah
     1561 tnsatssrpp ppftthsppt gsspfsstgp mtatsfkttt typtpshpqt tlpthvppfs
     1621 tslvtpstht vitpthaqma tsasihsmpt gtipppttlk atgsthtapt mtlttsgtsq
     1681 alsslntakt stslhshtss thhaeatsts ttnitpnpts tgtppmtvtt sgtsqsrssf
     1741 staktstslh shtssthhpe vtststtsit pnhtstgtrt pvahttsats srlptpftth
     1801 spptgttpis stgpvtatsf qttttyptps hphttlpthv psfstslvtp sthtviipth
     1861 tqmatsasih smptgtippp ttikatgsth tappmtptts gtsqspssfs taktstslpy
     1921 htssthhpev tptsttnitp khtstgtrtp vahttsasss rlptpftths pptgsspfss
     1981 tgpmtatsfq ttttyptpsh pqttlpthvp pfstslvtps thtviittht qmatsasihs
     2041 tptgtvpppt tlkatgstht appmtvttsg tsqthssfst atasssfiss sswlpqnsss
     2101 rppsspittq lphlssattp vsttnqlsss fspspsapst vssyvpsshs spqtsspsvg
     2161 tsssfvsapv hsttlssgsh sslsthptta svsasplfps spaasttira tlphtisspf
     2221 tlsallpist vtvsptpssh lasstiafps tprttastht apafssqstt srstslttrv
     2281 ptsgfvslts gvtgiptspv tnlttrhpgp tlspttrflt ssltahgstp asapvsslgt
     2341 ptptspgvcs vreqqeeitf kgcmanvtvt rcegacisaa sfniitqqvd arcsccrplh
     2401 syeqqlelpc pdpstpgrrl vltlqvfshc vcssvacgd
//